Abstract
We report a 54-year-old woman who received interferon alpha for haematological relapse of Ph-positive CML, 7 years after allogeneic BMT from an HLA-identical brother. Eighteen months after relapse, cytogenetic and molecular remission was achieved. She received interferon therapy for 25 months and it was discontinued when she developed skin lesions on her face and trunk, dysphagia and fever with respiratory failure and bilateral patchy airspace consolidation of the lung without microbiologic findings. Histologic features showed discoid lupus erythematosis, oesophagitis with pseudomembranes and a mixed pattern of lymphocytic bronchiolitis involving the alveoli and interstitial spaces all compatible with chronic GVHD. The patient was commenced on immunosuppressive therapy with complete clinical and radiological resolution. The available evidence supports an atypical presentation of chronic GVHD and suggests a role for interferon alpha in the pathogenesis of GVHD. To the best of our knowledge, this is the first case reported of severe chronic GVHD occurring during the course of interferon therapy for relapsed CML. Bone Marrow Transplantation (2001) 27, 85–87.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kolb HJ, Schatterberg A, Goldman JM et al. Graft-versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041–2050
Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 1995 86: 1261–1268
Bacigalupo A, Soraco M, Vassalto F et al. Donor lymphocyte infusions in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 927–932
Arcese W, Goldman JM, D'Arcangelo E et al. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia Blood 1993 82: 3211–3219
Higano CS, Chielens D, Raskind W et al. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation Blood 1997 90: 2549–2554
Steegmann JL, Casado LF, Tomas JF et al. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation Bone Marrow Transplant 1999 23: 483–488
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204–217
Sánchez J, Torres A, Serrano J et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation Bone Marrrow Transplant 1997 20: 403–408
Beard JS, Smith KL, Skelton HG . Combination chemotherapy with 5-fluorouracil, folinic acid and alpha-interferon producing histological features of graft-versus-host disease J Am Acad Dermatol 1993 29: 325–330
Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplantation for chronic myeloid leukemia: a clinico-pathological study Bone Marrow Transplant 1997 20: 83–85
Pavord S, Sivakumaran M, Durrant S, Chapman C . The role of alpha interferon in the pathogenesis of GVHD Bone Marrow Transplant 1992 10: 477
Browett PJ, Nelson J, Tiwari S et al. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukemia post-allogeneic bone marrow transplantation Bone Marrow Transplant 1994 24: 641–644
Metha J, Powles R, Kulkarni S et al. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients Bone Marrow Transplant 1997 20: 129–135
Klingemann HG, Grigg AP, Wilkie-Boyd K et al. Treatment with recombinant interferon (α-2b) early after bone marrow transplantation in patients at high risk for relapse Blood 1991 78: 3306–3311
Okanoue T, Sakamoto S, Itoh Y et al. Side effects of high-dose interferon therapy for chronic hepatitis C J Hepatol 1996 25: 283–291
Skoskiewicz MG, Colvin RB, Schneerburger EE, Russell PS . Histocompatibility complex-determined antigens in vivo by gamma interferon J Exp Med 1985 162: 1645–1664
Ghayur T, Seemayer TA, Kongshavn PA et al. Graft versus host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease Transplantation 1987 44: 261–267
Reyes VE, Klimpel GR . Interferon alpha/beta synthesis during acute graft versus host disease Transplantation 1987 43: 412–416
Cleveland MG, Lane RG, Klimpel GR . Enhaced interferon alpha/beta and defective interferon gamma production in chronic graft-versus-host disease: a potential mechanism for immunosuppression Cell Immunol 1987 110: 120–130
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Serrano, J., Prieto, E., Mazarbeitia, F. et al. Atypical chronic graft-versus-host disease following interferon therapy for chronic myeloid leukaemia relapsing after allogeneic BMT. Bone Marrow Transplant 27, 85–87 (2001). https://doi.org/10.1038/sj.bmt.1702746
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702746
Keywords
This article is cited by
-
Activation and regulation of interferon-β in immune responses
Immunologic Research (2012)
-
Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation
Bone Marrow Transplantation (2002)